NCT02091206: A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
- State
- Completed
- Phase
- Phase 2
- People
- 34 taking part
- Started
- 22 Oct 2014
- Primary completion
- 9 Mar 2015
- Arms
- GWP42003-P 5 mg/kg/day Dose, GWP42003-P 10 mg/kg/day Dose, GWP42003-P 20 mg/kg/day Dose
- Results
- Posted on the registry
- 19 Mar 2014: Trial registered
- 22 Oct 2014: Trial started
- 9 Mar 2015: Trial completed
- 19 Jul 2018: Trial results posted